Ключевые слова:
атерокальциноз, кальцификация сосудов, технеций-99m пирофосфат, сцинтиграфия, ОФЭКТ.Библиографические ссылки
Raggi P., Shaw L.J., Berman D.S., Callister T.Q. Prognostic value of coronary artery calcium screening in subjects with and without diabetes // J. Amer. Coll. Cardiol. – 2004. – Vol. 43, №9. – Р. 1663-1669.
Park S.Y., Cho I.H., Kim B.H. et al. Detection of vascular microcalcification using 99mTc-labeled diphosphonates: potential for early diagnosis of atherosclerosis // Nucl. Med. Commun. – 2017. – Vol. 38, №9. – Р. 747-753.
Irkle A., Vesey A.T., Lewis D.Y. et al. Identifying active vascular microcalcification by 18F-sodium fluoride positron emission tomography // Nat. Commun. – 2015. – Vol. 6. – Р. 7495.
Blau M., Nagler W., Bender M.A. Fluorine-18: a new isotope for bone scanning // J. Nucl. Med. – 1962. – Vol. 3, №5. – Р. 332-334.
Poterucha T.J., Elias P., Bokhari S. 99mTc-pyrophosphate scintigraphy: a practical guide for clinicians // J. Nucl. Cardiol. – 2018. – Vol. 25, №2. – Р. 659-670.
Rikhsiev A.Z., Sadikov I.I., Zikirov M. Evaluation of the suitability and safety of the radiopharmaceutical MDP99mTc (methylene diphosphonate) used for the diagnosis of bone patalogy in nuclear medicine // Int. J. Adv. Res. Sci. Engineer. Technol. – 2025. – Vol. 12, 4.